Related Experiment Video
Updated: Aug 7, 2026

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Case Report: Pemetrexed-induced pseudocellulitis: a rare adverse effect to be recognized for better management
Emma Proux1, Jeanne Chen2, Caroline Bonhomme3,4
1Dermatology Department, University Hospital of Nantes, Nantes, France.
Frontiers in Oncology
|October 24, 2025
Summary
Pemetrexed-induced pseudocellulitis (PIP) mimics infections but is an inflammatory reaction. Early recognition and corticosteroid treatment are key to avoiding unnecessary antibiotics and improving patient care.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Pseudocellulitis is a rare adverse reaction to pemetrexed.
- It mimics infectious cellulitis, leading to misdiagnosis and inappropriate treatments like antibiotics.
- Underrecognition contributes to delayed diagnosis and suboptimal patient management.
